The basic activitiy of CELL/TRY is to develop test cell systems, especially organotypic cultures for functional testing of medicines and biomaterials The test cell systems will be based on the primary cell cultures which offer the best approximation of the conditions in the living tissue and allow for determining biological variability of response to a medicine or biomaterial.

The products of this development will be used in preclinical testing of biopharmaceutical products and medicinal graft biomaterials and will enable the customers to:

  • Shorten the development time of biotechnological products and thus penetrate themarket faster
  • Make financial savings
  • Reduce the risk of failure in the phase of clinical testing